227
Participants
Start Date
January 23, 2024
Primary Completion Date
October 31, 2025
Study Completion Date
December 31, 2025
HDV-Lispro
HDV-L will be used as the mealtime insulin
Lispro
Lispro will be used as the mealtime insulin
SUNY Upstate Medical University, Syracuse
Virginia Endocrinology Research, Chesapeake
UNC EnDO Clinical Research Unit, Chapel Hill
Physician's East, Greenville
Asheville Clinical Research, Asheville
Physicians Research Associates, LLC, Lawrenceville
Endocrine Research Solutions, Inc., Roswell
East Coast Institute for Research, Canton
Atlanta Diabetes Associates, Atlanta
East Coast Institute for Research, Jacksonville
University of Miami Diabetes Research Institute, Miami
Metabolic Research Institute, West Palm Beach
University Hospitals Medical Center, Cleveland
Indiana Medical Research Institute, Merrillville
Endeavor Health, Skokie
University of Chicago Kovler Diabetes Center, Chicago
Tekton Research, LLC, Irving
Tekton Research, LLC, McKinney
Clinical Trials of Texas, San Antonio
Tekton Research, LLC, San Antonio
Texas Diabetes % Endocrinology, Round Rock
Texas Diabetes & Endocrinology, Austin
University of Colorado, Barbara Davis Center, Denver
Wasatch Clinical Research, LLC 310, Salt Lake City
Pasadena Clinical Trials, Pasadena
Marvel Clinical Research, Huntington Beach
Diabetes Research Center, Tustin
Lead Sponsor
Diasome Pharmaceuticlas, Inc.
INDUSTRY